JANNINE PURCELL: Open Payments
NPI 1184660086 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 13 payments from 7 companies in 2025. Trend: 2023 $265 · 2024 $414 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $300 |
| Janssen Biotech, Inc. | 4 | $196 |
| GENZYME CORPORATION | 1 | $122 |
| Janssen Scientific Affairs, LLC | 1 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $39 |
| Lilly USA, LLC | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $17 |
Products named: TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, ENTYVIO, OMVOH.
Industry payments across TX — which companies pay providers there.
